Nathaniel R. Primous
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nathaniel R. Primous has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Claudia Cristina Biguetti
School of Podiatric Medicine, Department of Surgery and Biomechanics, The University of Texas Health Science Center at Rio Grande Valley
1 shared publication - Hagner L. Andrade
Department of Podiatric Medicine, Surgery and Biomechanics, School of Podiatric Medicine, University of Texas Rio Grande Valley, Harlingen, TX 78550, USA
1 shared publication - Javier La Fontaine
School of Podiatric Medicine, University of Texas Rio Grande Valley, Harlingen, TX 78550, USA
1 shared publication - Kathleen V. Carter
Library, School of Medicine, University of Texas Rio Grande Valley, Harlingen, TX 78550, USA
1 shared publication - Naohiro Shibuya
The University of Texas Rio Grande Valley, School of Podiatric Medicine, 1214 W. Schooner St. 2.108, Edinburg, TX 78541, USA
1 shared publication - Peter T. Elvin
Department of Podiatric Medicine, Surgery and Biomechanics, School of Podiatric Medicine, University of Texas Rio Grande Valley, Harlingen, TX 78550, USA
1 shared publication
Latest Publications
- Open Access
- 21 February 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (5) , 1221
Bioengineered Skin for Diabetic Foot Ulcers: A Scoping Review
Diabetic foot ulcers (DFUs) pose a significant threat to individuals with diabetes mellitus (DM), such as lower limb amputation and severe morbidity. Bioengineered skin substitutes (BSS) are alternatives to traditional interventions for treating DFUs, but their efficacy compared to standard wound care (SWC) or other treatment types, such as allografts, remains unknown. A scoping review of human studies was conducted to identify current approaches in the treatment of DFUs using BSS as compared with other treatment options. Systematic searches in PubMed, Cochrane Library, and Web of Science were conducted to identify comparative studies that enrolled 10 or more patients and evaluated wound healing outcomes (closure, time-to-healing, and area reduction). Database searches isolated articles published from 1 December 2012 to 1 December 2022 and were conducted in accordance with PRISMA-ScR guidelines. The literature search yielded 1312 articles, 24 of which were included for the qualitative analysis. Findings in these studies demonstrated that BSS outperformed SWC in all measured outcomes, suggesting that BSS may be a superior treatment for DFUs. Of the 24 articles, 8 articles compared human amniotic membrane allografts (hAMA) to BSS. Conflicting evidence was observed when comparing BSS and hAMA treatments, highlighting the need for future research.
- 21 February 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (5) , 1221
Open AccessBioengineered Skin for Diabetic Foot Ulcers: A Scoping Review
Diabetic foot ulcers (DFUs) pose a significant threat to individuals with diabetes mellitus (DM), such as lower limb amputation and severe morbidity. Bioengineered skin substitutes (BSS) are alternatives to traditional interventions for treating DFUs, but their efficacy compared to standard wound care (SWC) or other treatment types, such as allografts, remains unknown. A scoping review of human studies was conducted to identify current approaches in the treatment of DFUs using BSS as compared with other treatment options. Systematic searches in PubMed, Cochrane Library, and Web of Science were conducted to identify comparative studies that enrolled 10 or more patients and evaluated wound healing outcomes (closure, time-to-healing, and area reduction). Database searches isolated articles published from 1 December 2012 to 1 December 2022 and were conducted in accordance with PRISMA-ScR guidelines. The literature search yielded 1312 articles, 24 of which were included for the qualitative analysis. Findings in these studies demonstrated that BSS outperformed SWC in all measured outcomes, suggesting that BSS may be a superior treatment for DFUs. Of the 24 articles, 8 articles compared human amniotic membrane allografts (hAMA) to BSS. Conflicting evidence was observed when comparing BSS and hAMA treatments, highlighting the need for future research.